hit counter
Axsome Therapeutics, Inc. (AXSM) Stock News Sentiment & Price - Sentifly
AXSM - Sentifly



Your watchlist is empty. Go add some tickers to it!

Axsome Therapeutics, Inc. (AXSM)

AXSM Price and Sentiment
Positive, Negative
Loading chart...
AXSM Latest news
Axsome Therapeutics to Report Third Quarter 2021 Financial Results on November 8, 2021
2021-10-20 07:00

Axsome to host conference call and webcast on Monday, November 8, 2021 at 8:00 AM Eastern Time

What's Happening With Axsome Therapeutics Stock?
2021-10-18 11:00

Last month we discussed that Axsome Therapeutics stock is likely to continue to see higher levels after it rose 6% in a week following the U.S. FDA's acceptance of a new drug application for the company's migraine drug - AXS-07. AXSM stock has since then rallied 27% to levels of nearly $38 now.

Axsome Therapeutics Expands Term Loan Facility with Hercules Capital to $300 Million
2021-10-18 07:00

$100 million now available upon the potential FDA approval of AXS-05

The Motley Fool
Why Axsome Therapeutics Stock Rocketed Higher This Week
2021-10-15 10:00

Optimism among investors is growing for the possible approval of the biotech's MDD drug.

The Motley Fool
1 Beaten-Down Stock With 10X Potential
2021-10-14 10:30

This biotech is down, but it isn't out just yet.

The Motley Fool
Why Axsome Therapeutics Stock Caught Fire in September
2021-10-06 10:45

This beaten-down biotech regained some lost ground last month.

SHAREHOLDER ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages Axsome Therapeutics, Inc. Investors with Losses Over $100K to Inquire About Class Action Investigation - AXSM
2021-09-29 22:03

NEW YORK, Sept. 29, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM) resulting from allegations that Axsome may have issued materially misleading business information to the investing public.

The Motley Fool
2 Best Biotech Stocks to Buy Right Now
2021-09-25 07:00

Aurinia Pharmaceuticals and Axsome Therapeutics are two names that growth investors should have on their radars right now.

Zacks Investment Research
Do Options Traders Know Something About Axsome (AXSM) Stock We Don't?
2021-09-24 15:21

Investors need to pay close attention to Axsome (AXSM) stock based on the movements in the options market lately.

Seeking Alpha
Axsome Therapeutics: Amid The FDA Difficulty Is A Huge Opportunity
2021-09-24 04:28

Among various companies being negatively impacted by a hypersensitive FDA environment, Axsome Therapeutics shares recently tumbled. Amid the aforesaid debacle, AXS-05 received a "stand by" notice from the FDA for its New Drug Application for major depressive disorder.

Loading more news...